Articles by David L. Stern - Pharmaceutical Executive


Articles by David L. Stern

e-Marketing at the Tipping Point

Feb 2, 2006

In 2004, US growth hormone sales reached nearly $711 million. But harsh restrictions on growth hormone treatments and their abuse as "lifestyle drugs" have injected controversy into the market. How can pharma ensure that its marketing efforts for products that help millions of children and adults reach the right targets?


Click here